Carcinoid and psychiatric symptoms.
D000328:Adult; D000342:Affective Symptoms / Q000453:epidemiology / Q000209:etiology; D000368:Aged; D001007:Anxiety / Q000209:etiology; D001921:Brain / Q000378:metabolism; D002276:Carcinoid Tumor / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D003520:Cyclophosphamide / Q000009:adverse effects; D003863:Depression / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D001523:Mental Disorders / Q000209:etiology*; D008784:Methysergide / Q000009:adverse effects; D008875:Middle Aged; D010468:Perceptual Disorders / Q000453:epidemiology / Q000209:etiology; D011569:Psychiatric Status Rating Scales; D012189:Retrospective Studies; D012701:Serotonin / Q000378:metabolism
D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D003520:Cyclophosphamide; D008784:Methysergide